Correlates of poor outcome among patients with bleeding after coronary interventions

Gjin Ndrepepa1, Elena Guerra, Stefanie Schulz

  • 1aDeutsches Herzzentrum, München b1.Medizinische Klinik rechts der Isar, Technische Universität cDZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.

Insights

Bleeding severity and site during percutaneous coronary intervention (PCI) significantly increase mortality risk. Cardiovascular factors like anemia and troponin levels also predict poor outcomes after PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Percutaneous coronary intervention (PCI) is a common procedure for coronary artery disease.
  • Bleeding complications during PCI are associated with increased morbidity and mortality.
  • Identifying risk factors for mortality in patients with PCI-related bleeding is crucial for improving patient management.

Purpose of the Study:

  • To identify factors associated with increased mortality risk in patients experiencing bleeding complications during PCI.
  • To analyze the impact of bleeding severity, bleeding site, and patient-specific factors on one-year all-cause mortality after PCI.

Main Methods:

  • A cohort of 1510 patients with periprocedural bleeding complications from a larger PCI patient group (14,180) was analyzed.
  • Bleeding was classified using Bleeding Academic Research Consortium (BARC) criteria.
  • One-year all-cause mortality was the primary outcome, assessed using Cox proportional hazards models.

Main Results:

  • A 6.9% mortality rate was observed within one year among patients with PCI-related bleeding.
  • Increased bleeding severity (BARC classes 3a-3c), non-access site bleeding, elevated troponin, multivessel disease, higher C-reactive protein, anemia, and platelet count were independent predictors of mortality.
  • Age and reduced estimated creatinine clearance approached statistical significance as mortality predictors.

Conclusions:

  • Bleeding characteristics, including severity and site, are key determinants of poor outcomes post-PCI.
  • Underlying cardiovascular risk factors significantly contribute to the increased mortality risk observed in patients with PCI-related bleeding.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890